This hypothesis proposes that selective upregulation of CXCL12 in astrocytes can restore CNS immune privilege by disrupting the CCL2 chemokine gradient that drives pathogenic monocyte infiltration. Rather than depleting CCR2+ monocytes systemically, this approach targets the upstream chemotactic signals by enhancing the competing CXCL12/CXCR4 axis specifically within CNS parenchyma. Astrocytes constitutively express low levels of CXCL12, which normally contributes to maintaining CNS homeostasis
Circulating hs-CRP as Disease-Modifying Target via Microglial IL-1β Amplification
Convergent vs Divergent Predictions
This summary checks where the selected hypotheses point toward the same target or mechanism, and where they pull in opposite directions.
Unspecified Mechanismimmunomics
Convergent signals
No same-target convergence detected in this selection.
Divergent signals
No direct polarity conflicts detected among the selected hypotheses.
Verdict Summary
3/11
dimensions won
CCL2 Gradient Disruption via Astrocytic
10/11
dimensions won
Circulating hs-CRP as Disease-Modifying
Radar Chart — 10 Dimensions
Score Comparison Bars
Mechanistic
0.55
0.55
Evidence
0.26
0.50
Novelty
0.00
0.60
Feasibility
0.00
0.45
Impact
0.00
0.40
Druggability
0.50
0.40
Safety
0.50
0.60
Competition
0.55
0.70
Data
0.40
0.65
Reproducible
0.45
0.55
KG Connect
0.50
0.50
Score Breakdown
Dimension
CCL2 Gradient Disruption via A
Circulating hs-CRP as Disease-
Mechanistic
0.550
0.550
Evidence
0.258
0.500
Novelty
0.000
0.600
Feasibility
0.000
0.450
Impact
0.000
0.400
Druggability
0.500
0.400
Safety
0.500
0.600
Competition
0.550
0.700
Data
0.400
0.650
Reproducible
0.450
0.550
KG Connect
0.500
0.500
Evidence
CCL2 Gradient Disruption via Astrocytic CXCL12 Upregulation
No evidence citations yet
Circulating hs-CRP as Disease-Modifying Target via Microglia
No evidence citations yet
Debate Excerpts
CCL2 Gradient Disruption via Astrocytic CXCL12 Upr
4 rounds · quality: 0.50
Theorist
# Novel Therapeutic Hypotheses: Systemic Immune Profiling in Neurodegeneration
---
## Hypothesis 1: Circulating hs-CRP as a Disease-Modifying Target via Microglial IL-1β Amplification
**Descripti...
Skeptic
# Critical Evaluation of Systemic Immune Profiling Hypotheses in Neurodegeneration
I will systematically evaluate each hypothesis, identifying specific weaknesses, counter-evidence with PubMed cita...
Domain Expert
# Expert Evaluation: Systemic Immune Profiling in Neurodegeneration
## Executive Summary
The seven hypotheses present a coherent framework linking peripheral immune dysregulation to CNS neurodegen...
Synthesizer
```json
{
"ranked_hypotheses": [
{
"rank": 1,
"id": "Hypothesis_1",
"title": "Circulating hs-CRP as Disease-Modifying Target via Microglial IL-1β Amplification",
"targe...
Circulating hs-CRP as Disease-Modifying Target via
4 rounds · quality: 0.50
Theorist
# Novel Therapeutic Hypotheses: Systemic Immune Profiling in Neurodegeneration
---
## Hypothesis 1: Circulating hs-CRP as a Disease-Modifying Target via Microglial IL-1β Amplification
**Descripti...
Skeptic
# Critical Evaluation of Systemic Immune Profiling Hypotheses in Neurodegeneration
I will systematically evaluate each hypothesis, identifying specific weaknesses, counter-evidence with PubMed cita...
Domain Expert
# Expert Evaluation: Systemic Immune Profiling in Neurodegeneration
## Executive Summary
The seven hypotheses present a coherent framework linking peripheral immune dysregulation to CNS neurodegen...
Synthesizer
```json
{
"ranked_hypotheses": [
{
"rank": 1,
"id": "Hypothesis_1",
"title": "Circulating hs-CRP as Disease-Modifying Target via Microglial IL-1β Amplification",
"targe...